1. Leukemia Pathogenesis & drug Resistance a. Investigating molecular drivers of leukemia progression and drug resistance mechanisms (e.g., glucocorticoid resistance); 2. CAR-T Immunotherapy a.Engineering novel CAR-T cell therapies against hematologic malignancies and solid tumors and translating preclinical findings into clinical trials. b.Developing approaches to reverse T-cell exhaustion and enhance immunotherapy responsiveness.
Hubei University of Technology
Wuhan, Hubei, China
school of life and heath science